Protocol summary

Summary
My objective is to test the comparison effect of Calendula and Turmeric(Curcuma Longa) ointment on healing and pain severity of episiotomy in primiparous women. 90 women who have episiotomy will be randomly divided into 2 intervention and 1 control group. one of the Intervention group will use Calendula ointment the other group will use Turmeric(Curcuma Longa) ointment on episiotomy incision every 8 hours.Control group will use Placebo on episiotomy incision. All groups in the ointment, receive routine care hospital.Our scale to check the wound healing is REEDA table. We check the healing process before and 3,7,10 , 14 days after intervention.Our scale to check the pain reliving is VAS ruler.We check the pain before and 3,7,10 , 14 days after intervention.

General information

Acronym
IRCT registration information
IRCT registration number: IRCT2015072023265N1
Registration date: 2015-08-10, 1394/05/19
Registration timing: registered_while_recruiting

Last update:
Update count: 0
Registration date
2015-08-10, 1394/05/19
Registrant information
Name
Elahe Mahmoudi
Name of organization / entity
Shiraz University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 71 4352 6842
Email address
stud2420062868@sums.ac.ir
Recruitment status
Recruitment complete
Funding source
Shiraz University of Medical Sciences
Expected recruitment start date
2015-07-23, 1394/05/01
Expected recruitment end date
2016-02-19, 1394/11/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison effect of Calendula and Turmeric(Curcuma Longa) ointment on healing and pain severity of episiotomy in primiparous women attending selected hospital of shiraz university of medical sciences 2015-1016.
Public title
Comparison effect of Calendula and Turmeric(Curcuma Longa) ointment on healing and pain severity of episiotomy.
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria: being primiparous; gestational age 37 to 42 weeks; vaginal delivery with episiotomy medio-lateral; havinng a singleton live child; cephalic presentation; pre-pregnancy body mass index less than 30; absence of reconstructive surgery on the vagina and perineum; do not use medications that effect wound healing; no specific disease( Anemia, cardiovascular disease, diabetes, immune dificiency, liver disease, depression, absence of coagulation disorders, preeclampsia, infectious diseases); lack of extending the incision and into the 3, 4 grade laceration or rupture exist except episiotomy. Exclusion criteria: manual removal of placenta; postpartum hemorrhage; hematoma formation; postpartum fever and chills(fever>38); manipulation of the perinum after delivery; episiotomy infections; need to re-stitch the episiotomy; the use of any ointment or cream other than what the researcher recives, Cause skin allergy by the use of ointment; unwillingness to continue to participate in the study.
Age
No age limit
Gender
Female
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size: 90
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Single blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethic Committee of Shiraz University of Medical Sciences
Street address
Shiraz University of Medical Sciences, Zand street
City
Shiraz
Postal code
Approval date
2015-06-21, 1394/03/31
Ethics committee reference number
IR.SUMS.REC.1394.40

Health conditions studied

1

Description of health condition studied
Episiotomy
ICD-10 code
O90.1
ICD-10 code description
Disruption of perineal obstetric wound

Primary outcomes

1

Description
Severity of episiotomy pain
Timepoint
Before intervention then 3,7,10,14 days after intervention
Method of measurement
Visual Analouga Scale(VAS)

Secondary outcomes

1

Description
Healing of episiotomy
Timepoint
Before intervention then 3,7,10,14 days after intervention
Method of measurement
REEDA (Redness, Edema, Ecchymosis, Discharge, Approximation).

2

Description
Number of Mefenamic acid capsules used
Timepoint
Tenth day after delivery
Method of measurement
count of remaining Capsules

Intervention groups

1

Description
Group1: mothers put Calendula on episiotomy 3 times a day of a knuckle until 7 days after birth.
Category
Treatment - Drugs

2

Description
Group2: mothers put Turmeric on episiotomy 3 times a day of a knuckle until 7 days after birth.
Category
Treatment - Drugs

3

Description
Control group: mothers put Placebo on episiotomy 3 times a day of a knuckle until 7 days after birth.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Hafez Hospital
Full name of responsible person
Miss Elahe Mahmoudi
Street address
Hafez Hospital, Chamran Boulvard
City
Shiraz

2

Recruitment center
Name of recruitment center
Zeynab Hospital
Full name of responsible person
Miss Elahe Mahmoudi
Street address
Zeynab Hospital, Zeynabiyeh Boulvard
City
Shiraz

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Gholam Reza Hatam
Street address
7th Floor, Shiraz University of Medical Sciences, Zand Street
City
Shiraz
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shiraz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Shiraz University of Medical Scienses
Full name of responsible person
Masoume Kaviani
Position
Master's degree in Midwifery, Faculty member
Other areas of specialty/work
Street address
Shiraz University of Medical Scienses, Zand street
City
Shiraz
Postal code
Phone
+98 71 3647 4253
Fax
Email
Kavianm@sums.ac.ir
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shiraz University of Medical Scienses
Full name of responsible person
Masoume Kaviani
Position
Master's degree in Midwifery, Faculty member
Other areas of specialty/work
Street address
Shiraz University of Medical Scienses, Zand street
City
Shiraz
Postal code
Phone
+98 71 3647 4253
Fax
Email
Kavianm@sums.ac.ir
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Shiraz University of Medical Scienses
Full name of responsible person
Masoume Kaviani
Position
Master's degree in Midwifery, Faculty member
Other areas of specialty/work
Street address
Shiraz University of Medical Scienses, Zand street
City
Shiraz
Postal code
Phone
+98 71 3647 4253
Fax
Email
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...